Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

 

Drugs and Chemicals of ConcernN,N-DIMETHYLTRYPTAMINE

Drugs and Chemicals of Concern


N,N-DIMETHYLTRYPTAMINE

(DMT)

August 2007 DEA/OD/ODE

Introduction:

N,N-Dimethyltryptamine (DMT) is the prototypical indolethylamine hallucinogen. The history of human experience with DMT probably goes back several hundred years since DMT usage is associated with a number of shamanic practices and rituals. As a naturally occurring substance in many species of plants, DMT is present in a number of South American snuffs and brewed concoctions, like Ayahuasca. In addition, DMT can be produced synthetically. The original synthesis was conducted by a British chemist, Richard Manske, in 1931.

DMT gained popularity as a drug of abuse in the 1960s and was placed under federal control in schedule I when the Controlled Substances Act was passed in 1971. Today, it is still encountered sporadically on the illicit market along with a number of other tryptamine hallucinogens.

Licit Use:

DMT has no approved medical use in the United States but can be used by researchers under a schedule I researcher registration that requires approval from both DEA and the Food and Drug Administration.

Chemical Structure:

All indolethylamine hallucinogens have the tryptamine molecule (see structure below) in their structural core. DMT is formed by substituting two methyl (CH3) groups for the two hydrogen (H) atoms on the terminal nitrogen of the ethylamine side chain of tryptamine.

Tryptamine Molecule DMT Molecule
Tryptamine  DMT

Pharmacology:

Administered alone, DMT is usually snorted, smoked or injected because the oral bioavailability of DMT is very poor unless it is combined with a substance that inhibits its metabolism. For example, in ayahuasca, the presence of harmala alkaloids (harmine, harmaline, tetrahydro-harmaline) inhibits the enzyme, monoamine oxidase which normally metabolizes DMT. As a consequence, DMT remains intact long enough to be absorbed in sufficient amounts to affect brain function and produce psychoactive effects.

In clinical studies, DMT was fully hallucinogenic at doses between 0.2 and 0.4 mg/kg. The onset of DMT effects is very rapid but usually resolves within 30 to 45 min. Psychological effects include intense visual hallucinations, depersonalization, auditory distortions and an altered sense of time and body image. Physiological effects include hypertension, increased heartrate, agitation, seizures, dilated pupils, nystagmus (involuntary rapid rhythmic movement of the eye), dizziness and ataxia (muscular incoordination). At high doses, coma and respiratory arrest have occurred.

Illicit Use:

DMT is used for the psychoactive effects it produces. The intense effects and short duration of action are attractive to individuals who want the psychodelic experience but do not choose to experience the mind altering perceptions over an extended period of time as occurs with other hallucinogens, like LSD.

DMT is generally smoked or consumed orally in brews like Ayahuasca. Like most other hallucinogens, DMT is not associated with physical dependence or addiction.

Illicit Distribution:

DMT is found in a number of plant materials and can be extracted or synthetically produced in clandestine labs. Like other hallucinogens, Internet sales and distribution have served as the source of drug supply in this country. According to the System to Retrieve Information from Drug Evidence (STRIDE), a federal database for the seized drugs samples analyzed by DEA forensic laboratories, there were 71 drug records and 31 cases involving DMT during 1996 - 2006. The amounts of drug seized included 10 tablets, 157.562 kilograms of powder and 462.9 liters of liquid containing DMT. According to the National Forensic Laboratory Information System (NFLIS), there were a total of 65 state and local cases involving 82 DMT containing drug items during 1999 - 2006. According to STRIDE and NFLIS, DMT has been encountered in a number of states including Alaska, Arkansas, California, Colorado, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Louisiana, Maryland, Missouri, Minnesota, Montana, New Mexico, New York, Oregon, Pennsylvania, Tennessee, Utah, Virginia, Washington, Wisconsin and District of Columbia

Control Status:

DMT is controlled in schedule I of the Controlled Substances Act.

Comments and additional information are welcomed by the Drug and Chemical Evaluation Section, FAX 202-353-1263 or telephone 202-307-7183.


     HOME

CONTACT US

SEARCH

BACK TO TOP